The Jab: Why can’t more be made?

Thousands are dying each day amid vaccine shortages. Would a patent waiver save lives?Jayati Ghosh of the University of Massachusetts Amherst says liberating IP is an urgent moral issue. Richard Hatchett, CEO at CEPI, disagrees.Alok Jha and Natasha Loder are joined by Edward Carr, our deputy editor, and economics columnist Ryan Avent.For full access to The Economist’s print, digital and audio editions subscribe at economist.com/thejabpod. Sign up for our new weekly science and data newsletters at economist.com/simplyscience and economist.com/offthecharts Hosted on Acast. See acast.com/privacy for more information.

Om Podcasten

The Economist unlocks the science, data and politics behind the most ambitious inoculation programme the world has ever seen.Alok Jha, The Economist’s science correspondent, hosts with Natasha Loder, our health-policy editor. Each week our reporters and data journalists join them in conversation, along with scientists around the world.Sign up for Economist Podcasts+ at www.economist.com/podcastsplusIf you’re already a subscriber to The Economist, you’ll have full access to all our shows as part of your subscription. Hosted on Acast. See acast.com/privacy for more information.